CINECA IRIS Institutional Research Information System

TALIANI, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.896
AS - Asia 10.252
EU - Europa 8.784
SA - Sud America 1.282
AF - Africa 465
OC - Oceania 69
Continente sconosciuto - Info sul continente non disponibili 3
Totale 39.751
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.240
IT - Italia 3.555
SG - Singapore 3.015
CN - Cina 2.698
HK - Hong Kong 1.407
VN - Vietnam 1.394
SE - Svezia 1.239
BR - Brasile 1.042
DE - Germania 902
BG - Bulgaria 551
CA - Canada 501
GB - Regno Unito 446
TR - Turchia 431
FR - Francia 411
FI - Finlandia 381
AT - Austria 318
RU - Federazione Russa 312
JP - Giappone 278
IN - India 270
UA - Ucraina 209
KR - Corea 189
CI - Costa d'Avorio 104
BD - Bangladesh 99
NG - Nigeria 86
CH - Svizzera 85
IQ - Iraq 78
MX - Messico 77
NL - Olanda 74
AR - Argentina 71
SN - Senegal 64
AU - Australia 63
ZA - Sudafrica 59
PL - Polonia 58
BE - Belgio 56
PK - Pakistan 55
ES - Italia 51
ID - Indonesia 45
SA - Arabia Saudita 42
UZ - Uzbekistan 40
CO - Colombia 34
VE - Venezuela 34
EC - Ecuador 32
EG - Egitto 31
KE - Kenya 28
JO - Giordania 25
MA - Marocco 22
CZ - Repubblica Ceca 20
IE - Irlanda 18
MY - Malesia 18
PY - Paraguay 18
AZ - Azerbaigian 17
DZ - Algeria 17
JM - Giamaica 17
LT - Lituania 16
CL - Cile 15
PE - Perù 15
PH - Filippine 14
TT - Trinidad e Tobago 14
AE - Emirati Arabi Uniti 13
KZ - Kazakistan 13
OM - Oman 13
ET - Etiopia 12
IR - Iran 12
TW - Taiwan 12
IL - Israele 11
PT - Portogallo 11
BO - Bolivia 10
HU - Ungheria 10
LB - Libano 10
AL - Albania 9
CR - Costa Rica 8
GE - Georgia 8
GR - Grecia 8
PA - Panama 8
BJ - Benin 7
DK - Danimarca 7
UY - Uruguay 7
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
BF - Burkina Faso 5
BH - Bahrain 5
BN - Brunei Darussalam 5
DO - Repubblica Dominicana 5
EE - Estonia 5
NP - Nepal 5
PR - Porto Rico 5
RO - Romania 5
TN - Tunisia 5
BY - Bielorussia 4
LY - Libia 4
NI - Nicaragua 4
QA - Qatar 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CG - Congo 3
GT - Guatemala 3
GY - Guiana 3
HR - Croazia 3
KG - Kirghizistan 3
Totale 39.688
Salva come PNG Salva come JPEG
Città #
Ashburn 1.826
Woodbridge 1.762
Singapore 1.683
Ann Arbor 1.493
Hong Kong 1.363
Houston 1.321
Serra 1.185
San Jose 1.134
Fairfield 1.039
Chandler 1.031
Santa Clara 947
Dallas 866
Milan 655
Sofia 550
Beijing 528
Shanghai 527
New York 435
Seattle 427
Wilmington 397
Ho Chi Minh City 383
Ottawa 377
Los Angeles 341
Cambridge 327
Boardman 298
Council Bluffs 292
Hanoi 283
Izmir 282
Vienna 267
Princeton 264
Jacksonville 252
Hefei 251
Lawrence 220
Lauterbourg 217
Tokyo 203
Frankfurt am Main 192
Nanjing 177
Seoul 177
Medford 175
London 167
Des Moines 154
Dong Ket 147
Helsinki 143
Pisa 142
Rho 129
Istanbul 107
Rome 105
Abidjan 104
Redondo Beach 103
Dearborn 102
Munich 88
Buffalo 85
São Paulo 84
Lagos 83
Bremen 75
Florence 73
Chicago 72
Da Nang 64
Dakar 64
San Diego 62
Columbus 61
Nanchang 60
Turku 60
Brussels 55
Bern 54
Orem 52
The Dalles 50
Redwood City 49
Boulder 48
Ogden 48
Haiphong 46
Kunming 45
Lucca 45
Warsaw 45
Düsseldorf 42
Pune 42
Jüchen 41
Sydney 41
Changsha 38
Fuzhou 38
Shenyang 38
Tashkent 38
San Francisco 37
Toronto 36
Hebei 35
Johannesburg 34
Paris 32
Belo Horizonte 31
Livorno 31
Tianjin 31
Baltimore 30
Dhaka 29
Rio de Janeiro 29
Manchester 28
Guangzhou 27
Montreal 27
Nuremberg 27
Nürnberg 27
Baghdad 26
Phoenix 26
Quanzhou 26
Totale 27.905
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 416
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 333
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 299
N, N-Dialkyl-2-phenylindol-3-ylglyoxylamides.A new class of potent and selective ligands at the Peripheral benzodiazepine receptor 294
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 279
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 275
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 272
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 270
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 256
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells 254
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 246
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 244
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: a New Class of Selective Aldose Reductase Inhibitors 236
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 233
TSPO-ligands prevent oxidative damage and inflammatory response in C6 glioma cells by neurosteroid synthesis 232
Allosteric modulators of human A2B adenosine receptor. 231
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 231
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives. 229
Metformin conjugates and therapeutic use thereof 226
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 223
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: A New Class of Selective Aldose Reductase Inhibitors 223
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 218
p53 Functional Inhibitors Behaving Like Pifithrin-β Counteract the Alzheimer Peptide Non-β-amyloid Component Effects in Human SH-SY5Y Cells. 217
Structure-Based Lead Optimization and Biological Evaluation of BAX Direct Activators as Novel Potential Anticancer Agents. 216
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 214
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: Tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands 213
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 213
An update into the medicinal chemistry of translocator protein (TSPO) ligands 213
TSPO Radioligands for Neuroinflammation: An Overview 211
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 210
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 210
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: A New Class of Selective A1 Adenosine Receptor Antagonists 209
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 209
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 207
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 206
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 205
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 205
Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173 204
Geometrically Constrained Analogues N-Benzylindolylglyoxylylamides: [1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one Derivatives as Potential New Ligands at the Benzodiazepine Receptor. 202
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 202
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 201
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 201
Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands 200
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 199
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 199
Studies in search for selective ligands for GABAA/BzR receptor subtypes: synthesis and biological evaluation of 4'-modified N-(benzyl)indol-3-ylglyoxylamides 198
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 198
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 198
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 196
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 194
2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of selective Antagonists at Human A1 and A3 Adenosine Receptors Designed by 3D Database Searching 194
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 194
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 194
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 194
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 193
"2-Phenyl[1,2,3]triazole[1,2-a][1,2,4]triazin-1,5(6H)-dione: a derivative of a new tricyclic heteroaromatic system with high affinity at the benzodiazepine receptor" 192
11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain 192
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 191
Synthesis of a Novel Purine-Containing Heterocyclic Ring System: 8,10-Dimethylindolo[2',3':5,6][1,2,4]triazino[4,3-f]purine-9,11(8H,10H,13H)dione 191
The Anxiolytic Etifoxine Binds to TSPO Ro5-4864 Binding Site with Long Residence Time Showing a High Neurosteroidogenic Activity 191
Osteoblast differentiation and survival: A role for A2B adenosine receptor allosteric modulators. 190
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 190
Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 189
Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) ligands 189
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 189
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 188
3-(Fur-2-yl)-10-(2-Phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with (2A)-Mediated Neuroprotective EffeCTS 187
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 186
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 186
The human microglial surveillant phenotype is preserved by de novo neurosteroidogenesis through the control of cholesterol homeostasis: Crucial role of 18 kDa Translocator Protein 184
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 184
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 184
Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic Activity 184
Novel Pyrazolo[3,4-d]pyrimidine Derivatives as ATP-competitive Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase 183
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 183
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 182
Sex Differences in Blood Accumulation of Neurodegenerative-Related Proteins and Antioxidant Responses to Regular Physical Exercise 181
Novel Potent and Selective Human Adenosine A3 Receptor Antagonists Containing the Pyrazolo[3,4-d]pyrimidine Ring System. Synthesis and Biological Evaluation 179
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 179
Antitumoral effect by induction of collapse of mitochondrial membrane potential in Glioblastoma Multiforme cells 177
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 177
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 177
Characterization of a new fluorescent irreversible ligand to translocator protein (18 kDa) 176
De novo neurosteroidogenesis in human microglia: Involvement of the 18 kda translocator protein 175
Carbonic anhydrase activation profile of indole-based derivatives 174
null 173
Synthesis and Biological Evaluation of 4-Phenylquinazoline-2-carboxamides Designed as a Novel Class of Potent Ligands of the Translocator Protein 172
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells 172
Nuovi derivati acidi acetici quali potenti inibitori dell’Aldoso Reduttasi 171
Synthesis of Pyrimido[1,2-a]benzimidazol-4(10H)-one Derivatives and Evaluation of their Interactions with DNA 171
Highlighting the new advances in drug discovery and development 171
Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABA(A) receptor activity 171
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 171
New fluorescent probes for the pheripheral-type benzodiazepine receptor: synthesis and biological application 170
Pyrazolo[3,4,-d]pyrimidine-4-one Derivatives as Novel and Potent Inhibitors of Adenosine Deaminase 170
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 170
Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex. 170
Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model 169
Exploiting the 4-Phenylquinazoline Scaffold for the Development of High Affinity Fluorescent Probes for the Translocator Protein (TSPO) 168
Synthesis and Biological Evaluation of Pyrido[1,2-d]pyrimidin-4-one Derivatives as Novel Aldose Reductase Inhibitors Exhibiting Antioxidant Activity 167
Totale 20.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.662 79 229 119 142 421 377 100 116 95 72 147 765
2022/20233.787 449 581 274 373 421 483 39 276 643 22 177 49
2023/20242.829 310 282 306 190 406 505 174 72 39 68 165 312
2024/20258.212 60 286 103 526 853 829 570 370 754 1.061 872 1.928
2025/202610.170 472 1.134 1.085 774 978 791 2.200 478 655 916 400 287
2026/202751 51 0 0 0 0 0 0 0 0 0 0 0
Totale 40.408